Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users

International Journal of Cardiology

Volumn 88, Issue 2-3, 2003, Pages 191-198

  Meng, Qingyi ^a,b   Lima, Joao A ^a   Lai, Hong ^a   Vlahov, David ^c   Celentano, David D ^d   Margolick, Joseph B ^d   Lai, S ^d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Calcium; Cocaine; CRP; Echocardiography; Endothelial function; Lipid

Indexed keywords

C REACTIVE PROTEIN; COCAINE; LIPID;

ADULT; ARTERY CALCIFICATION; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIASTOLE; ECHOCARDIOGRAPHY; ENDOTHELIUM; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

EID: 0037398385     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00394-7     Document Type: Article

References (22)

1. Ridker P.M., Haughie P. Prospective studies of C-reactive protein as a cardiovascular disease. J Invest Med. 46:1998;391-395.
2. Lowe G.D.O., Yarnell J.W.G., Rumley A., Bainton D., Sweetnam P.M. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the speedwell study. Arterioscler Thromb Vasc Biol. 21:2001;603-610.
3. Eisenberg M.S., Chen H.J., Warshofsky M.K., Sciacca R.R., Wasserman H.S., Schwartz A., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation. 102:2000;2100-2104.
4. Vogel R.A. Cholesterol lowering and endothelial function. Am J Med. 107:1999;479-487.
5. Quyyumi A.A. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med. 105:1998;32S-39S.
6. Kleerup E.C., Wong M., Marques-Magallanes J.A., Goldman M.D., Tashkin D.P. Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. Chest. 111:1997;30-35.
7. Anthony J.C., Vlahov D., Celentano D.D., Menon A.S., Margolick J.B., Cohn S., et al. Self-reported interview data for a study of HIV-1 infection among intravenous drug users: description of methods and preliminary evidence on validity. J Drug Issues. 21:1991;739-757.
8. Celermajer D.S., Sorensen K.S., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
9. Woo K.S., McCrohon J.A., Chook P., Adams M.R., Robinson J.T.C., McCredie R.J., et al. Chinese adults are less susceptible than whites to age-related endothelial dysfunction. J Am Coll Cardiol. 30:1997;113-118.
10. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of concentration of low-density lipoprotein cholesterol in serum without the use of ultracentrifuge. Clin Chem. 18:1991;685-690.
11. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 45:1999;2136-2141.
12. Meier-Ewert H.K., Ridker P.M., Rifai N., Price N., Dinges D.F., Mullington J.M. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 47:2001;426-430.
13. Henri W.L., De Maria A., Gramiak R. Report of the American Society of Cardiography committee on nomenclature and standards in two-dimensional echocardiography. Circulation. 62:1980;212-217.
14. Devereux R.B., Riechek N. Echocardiographic determination of left ventricular mass in man, anatomic validation of the method. Circulation. 55:1977;613-618.
15. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 15:1990;827-832.
16. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., et al. Chronic infections and the risk of carotid atherosclerosis. Circulation. 103:2001;1064-1071.
17. Ridker P.M. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 103:2001;1813-1821.
18. Om A. Cardiovascular complications of cocaine. Am J Med Sci. 303:1992;333-339.
19. Devi B.G., Chan A.W.K. Effect of cocaine on cardiac biochemical functions. J Cardiovasc Pharm. 33:(1):1999;1-6.
20. Minor R.L., Scott B.D., Brown D.D., Winniford M.D. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med. 115:1991;797-806.
21. Greiner D.Z., Personius B.E., Andrews T.C. Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease. Am J Cardiol. 83:1999;247-249.
22. Devi B.G., Chan A.W.K. Effect of cocaine on cardiac biochemical functions. J Cardiovasc Pharm. 33:(1):1999;1-6.